These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29072428)

  • 1. Long-Term Disease-Free Survival of Non-Metastatic Breast Cancer Patients in Iran: A Survival Model with Competing Risks Taking Cure Fraction and Frailty into Account.
    Ghavami V; Mahmoudi M; Rahimi Foroushani A; Baghishani H; Homaei Shandiz F; Yaseri M
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2825-2832. PubMed ID: 29072428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Spatial Survival Model in Presence of Competing Risks for Iranian Gastrointestinal Cancer Patients.
    Hesam S; Mahmoudi M; Rahimi Foroushani A; Yaseri M; Mansournia MA
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2947-2954. PubMed ID: 30362330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
    Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure frailty models for survival data: application to recurrences for breast cancer and to hospital readmissions for colorectal cancer.
    Rondeau V; Schaffner E; Corbière F; Gonzalez JR; Mathoulin-Pélissier S
    Stat Methods Med Res; 2013 Jun; 22(3):243-60. PubMed ID: 21632696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of the cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models.
    Ghadimi M; Mahmoodi M; Mohammad K; Zeraati H; Rasouli M; Sheikhfathollahi M
    BMC Gastroenterol; 2011 Oct; 11():104. PubMed ID: 21961837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint frailty model for recurrent events and death in presence of cure fraction: Application to breast cancer data.
    Talebi-Ghane E; Baghestani A; Zayeri F; Rondeau V; Akhavan A
    Biom J; 2021 Apr; 63(4):725-744. PubMed ID: 33368665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling time-to-cure from severe acute malnutrition: application of various parametric frailty models.
    Banbeta A; Seyoum D; Belachew T; Birlie B; Getachew Y
    Arch Public Health; 2015; 73(1):6. PubMed ID: 25973196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model.
    Zarean E; Azizmohammad Looha M; Amini P; Mahmoudi M; Azimi T
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1677-1683. PubMed ID: 29938465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety of breast-conserving treatment for triple-negative breast cancer].
    Wang L; Ouyang T; Wang T; Xie Y; Fan Z; Fan T; Li J
    Zhonghua Wai Ke Za Zhi; 2015 Dec; 53(12):947-52. PubMed ID: 26850668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.
    Azizmohammad Looha M; Pourhoseingholi MA; Nasserinejad M; Najafimehr H; Zali MR
    Epidemiol Health; 2018; 40():e2018045. PubMed ID: 30220192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer.
    Cabarrou B; Belin L; Somda SM; Falcou MC; Pierga JY; Kirova Y; Delord JP; Asselain B; Filleron T
    Breast Cancer Res Treat; 2016 Apr; 156(3):577-585. PubMed ID: 27075918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer.
    Stedman MR; Feuer EJ; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estimation of long and short term survival time and associated factors of HIV patients using mixture cure rate models.
    Ghobadi KN; Roshanaei G; Poorolajal J; Shakiba E; KHassi K; Mahjub H
    BMC Med Res Methodol; 2023 May; 23(1):123. PubMed ID: 37217850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the Factors Affecting Long-Term and Short-Term Survival of Breast Cancer Patients in Rafsanjan Using a Mixture Cure Model.
    Jahani S; Hoseini M; Pourhamid R; Askari M; Moslemi A
    J Res Health Sci; 2021 May; 21(2):e00516. PubMed ID: 34465639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gibbs sampling for long-term survival data with competing risks.
    Chao EC
    Biometrics; 1998 Mar; 54(1):350-66. PubMed ID: 9544528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical likelihood inference on clustered competing risks data.
    Christian NJ; Ha ID; Jeong JH
    Stat Med; 2016 Jan; 35(2):251-67. PubMed ID: 26278918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating hospital heterogeneity with a competing risks frailty model.
    Rueten-Budde AJ; Putter H; Fiocco M
    Stat Med; 2019 Jan; 38(2):269-288. PubMed ID: 30338563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.